EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Extracorporeal cytokine adsorption as therapeutic option for immune effector cell-associated neurotoxicity syndrome

Alix Buhlmann, Emanuel Rom, Giovanna Schweiger, Dominik Schneidawind, Sascha David

Neurological Sciences · 2025-01 · 46 (1) · 479-481

DOI: 10.1007/s10072-024-07812-1 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Neurological Sciences, online erschienen am 17.10.2024. Verfasst von Alix Buhlmann und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Intensive Care Medicine, University Hospital Zurich, Rämistrasse 100, Zurich, 8091, Switzerland. Hauptthemen laut MEDLINE: Neurotoxicity Syndromes, Cytokines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Zurich.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the rising number of patients receiving chimeric antigen receptor T-cells, the treatment of this therapy’s complications is of growing concern to intensivists and neurologists. We used extracorporeal cytokine adsorption as an add-on therapy in a patient suffering from immune effector cell-associated neurotoxicity syndrome. Interleukin-6 level, which as a readily available parameter is generally used to evaluate course of disease, was rapidly reduced using this method. The patient made a full recovery and is still in hematological remission.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurotoxicity SyndromesCytokinesHumansMaleImmunotherapy, AdoptiveInterleukin-6Female

Stichwörter der Autor:innen

Blood PurificationClearanceHemoperfusionRemoval

Substanzen

CytokinesInterleukin-6cell-associated neurotoxicity

Autor:innen und Institutionen

  • Institute of Intensive Care Medicine, University Hospital Zurich, Rämistrasse 100, Zurich, 8091, Switzerland.
  • Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.
  • Institute of Anesthesiology, University Hospital Zurich, Zurich, Switzerland.
  • Institute of Intensive Care Medicine, University Hospital Zurich, Rämistrasse 100, Zurich, 8091, Switzerland. sascha.david@usz.ch.

Förderung

  • University of Zurich

Zitieren

APA

Buhlmann, A., Rom, E., Schweiger, G., Schneidawind, D., & David, S. (2025). Extracorporeal cytokine adsorption as therapeutic option for immune effector cell-associated neurotoxicity syndrome. Neurological Sciences, 46(1), 479-481. https://doi.org/10.1007/s10072-024-07812-1

Vancouver

Buhlmann A, Rom E, Schweiger G, Schneidawind D, David S. Extracorporeal cytokine adsorption as therapeutic option for immune effector cell-associated neurotoxicity syndrome. Neurological Sciences. 2025;46(1):479-481. doi:10.1007/s10072-024-07812-1

BibTeX
@article{Buhlmann2025,
  author = {Buhlmann, Alix and Rom, Emanuel and Schweiger, Giovanna and Schneidawind, Dominik and David, Sascha},
  title = {Extracorporeal cytokine adsorption as therapeutic option for immune effector cell-associated neurotoxicity syndrome},
  journal = {Neurological Sciences},
  year = {2025},
  volume = {46},
  number = {1},
  pages = {479--481},
  doi = {10.1007/s10072-024-07812-1}
}
Kostenlos starten →